1.
Dourthe ME, Phulpin A, Auperin A, Bosq J, Couec M-L, Dartigues P, Ducassou S, Garnier N, Haouy S, Leblanc T, Leruste A, Paillard C, Rigaud C, Simonin M, Patte C, Minard-Colin V. Rituximab in addition to LMB-based chemotherapy regimen in children and adolescents with primary mediastinal large B-cell lymphoma: results of the French LMB2001 prospective study. Haematologica 2022;107(9):2173-2182; https://doi.org/10.3324/haematol.2021.280257.